Latest Past Events
Johnson & Johnson Innovation, JLABS with MSIP: This Little Med-Device Went to Market: Health Economics & Market Access
Hess Seminar Room B 1470 Madison Ave, New YorkBeyond the challenges associated with gaining regulatory approval, there are hurdles to overcome as you enter the real world with your innovation. Many of these challenges can be addressed through understanding the non-clinical as well as clinical situation and building integrated plans to quantify and communicate the value of your solution with evidence, drive market access, reimbursement and adoption. On October 24, learn from Brian Vaughn, Leader, ETHICON Franchise Health Economics and Market Access and Diane Francis, Sr. Director, US Field Health Economics & Market Access. Brian and Diane are part of the Johnson & Johnson Medical Device Health Economics and Market Access Center of Excellence and will discuss today's market access landscape for medical devices and how to ensure you are starting early with a plan to succeed. Following the presentation, don't miss the opportunity to apply for a one-on-one meeting with these experts as a forum to further discuss your specific market access needs. Agenda: 1:00 PM | Registration opens, Lunch & Networking 1:30 PM | Presentation 2:30 PM | Q&A 3:00 PM | Program Close 3:00 PM - 5:00 PM | One-on-one Meetings* To register, visit: https://www.eventbrite.com/e/nyc-session-this-little-med-device-went-to-market-health-economics-market-access-tickets-36788224570
New York Academy of Sciences: Towards Transformative Therapies for Sick Cell Disease
Sickle Cell Disease (SCD) is a debilitating blood disorder with high mortality rates, yet to date only a single therapy for the disease has been approved by the FDA. Markedly, improved insight into the complex pathophysiology of SCD has led to the recent development of diverse approaches for treatment, including inhibition of hemoglobin polymerization, prevention and treatment of vaso-occlusive events, and disease corrective gene therapy approaches. This symposium will discuss these recent developments highlighting key biological mechanisms of disease and reviewing relevant clinical science around SCD, while underscoring the importance of the patient experience. Learn more about pricing and the agenda here.
The ABC’s of SBIR/STTR Funding
Weill Cornell Medicine Greenberg Center 1305 York Ave., New YorkThis two-hour program will cover the basics of the government's SBIR and STTR programs, and help participants determine if they should pursue this compelling source of non-dilutive funding. Information covered in this session will include: An overview of what the SBIR/STTR programs fund Eligibility requirements How SBIR and STTR differ How to select which of the 11 participating agencies is right for your technology Key components of a competitive proposal Register